SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-008788
Filing Date
2024-03-20
Accepted
2024-03-20 19:57:52
Documents
2
Period of Report
2024-03-13

Document Format Files

Seq Description Document Type Size
1 form3-03202024_110345.html 3  
1 form3-03202024_110345.xml 3 6764
2 ex24-03202024_110346.htm EX-24 6119
  Complete submission text file 0001415889-24-008788.txt   14362
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10975 N. TORREY PINES RD., SUITE 150 LA JOLLA CA 92037
Business Address
Kim Jae B. (Reporting) CIK: 0001819159 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40288 | Film No.: 24769104